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Summary 
In presenting a unifying concept for chronic inflammation and lymphoid organogenesis, we 
suggest that lymphotoxin's (LT, LT-ot, TNF-J3) crucial role in these processes is pivotal and 
similar.  Chronic inflammatory lesions that developed in the kidney and pancreas at the sites of 
transgene expression in rat insulin promoter-LT (RIP-LT) mice resembled lymph nodes with 
regard to cellular composition (T cells, B cells, plasma cells, and antigen-presenting cells), de- 
lineated T  and B cell areas, primary and secondary follicles, characteristic morphologic and an- 
tigenic (ICAM-1, VCAM-1,  MAdCAM-1,  and PNAd) features of high endothelial venules, 
and ability to respond to antigen and undergo Ig class switching when obtained from mice im- 
munized with SRBC. The vascular changes, with the exception of PNAd, appear to be the di- 
rect consequence of transgene derived LT expression, as they were also  observed in RIP-LT 
mice lacking mature T and B cells. These data show that LT-induced chronic inflammation has 
the characteristics of organized lymphoid tissue. 
C 
hronic  inflammation,  a  complex  pathophysiologic 
process characterized by an accumulation of mononu- 
clear cells, is associated with the response to invading patho- 
gens, neoplastic transformation, or autoimmune recognition 
of self-antigens. This is usually initiated by events involving 
macrophages  and  T  cells  and  is  perpetuated through  re- 
cruitment of additional T  cells, B  cells,  and macrophages. 
The process can lead to elimination of the pathogen or tu- 
mor, but frequently results in tissue  damage. The cells in 
the infiltrate influence the severity of clinical signs and, in 
addition to the  elimination of the  causative stimulus,  can 
perpetuate the lesion, resulting in exacerbation in diseases 
such  as  multiple  sclerosis  and  rheumatoid  arthritis.  They 
can also contribute to resolution of the lesion through sup- 
pression of inflammatory activity (1). Although the classical 
definition of chronic inflammation includes tissue  destruc- 
tion and loss of  function (2), several instances of chronic in- 
flammation have been described in which cellular infiltra- 
tion occurs without tissue destruction. These include insulitis 
in male non obese diabetic (NOD) 1 mice (3) and thyroidi- 
tis in biobreeding (BB) rats  (4).  In several other situations, 
chronic, long lasting inflammation can eventually lead to 
]  Abbrem'ations used in this paper: BB, biobreeding;  EAE, experimental  al/er- 
gic encephalomyelitis',  HEV, high endothelial  venules; LT, lymphotoxin; 
NOD, non obese diabetic; PFC, plaque-forming  cell; PLP, periodate/ 
lysine/paraformaldehyde;  RIP, rat insulin promoter. 
tissue damage. Such is the case with female NOD mice, in 
whom insulitis  begins as early as four weeks of age, but tis- 
sue damage and islet destruction is not seen until the age of 
three months. In rat insulin promoter-TNF-~t (RIP-TNF- 
or), RIP-lymphotoxin  (RIP-LT),  or RIP-IL-2  mice,  in- 
flammation is apparent in very young mice  (before three 
weeks of age) but tissue  damage occurs after costimulatory 
signals or upon antigenic stimulation (5-8). 
The development and organization of chronic inflamma- 
tion is just beginning to be understood. Though several cy- 
tokines and chemokines have been implicated, a clear un- 
derstanding of the role of the individual factors and their 
mechanism  of action  in  the  inflammatory process  awaits 
elucidation.  Although  the  expression  "tertiary  lymphoid 
tissue" has been used to describe any tissue that can be in- 
filtrated (9), the process of chronic inflammation had been 
considered to  be  completely different from that  of lym- 
phoid organ development. 
Lymphotoxin (LT, also  known as LT-ot or TNF-[~),  a 
product of CD4Thl, CD8, and early B cells, has been im- 
plicated in the  inflammatory process though  it has  many 
other activities as well (reviewed in 10). A major role in in- 
flammation is implied from its ability to activate endothelial 
cells in vitro for the expression of the adhesion molecules 
ICAM-1 and VCAM-1  (11,  12). Studies with T  cell clones 
indicate its importance (with TNF-ot) in the transfer of ex- 
perimental allergic encephalomyelitis (EAE)  (13,  14).  The 
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part to the upregulation of VCAM-1 in the CNS (15) and 
the extent of inflammation is positively correlated with ex- 
pression  of that  adhesion  molecule.  Inhibition  of LT and 
TNF-ot  in  this  situation  prevents  the  upregulation  of 
VCAM-1  and the  subsequent  recruitment  of additional  T 
cells,  B  cells,  and macrophages (15). 
LT induces  inflammation  at  sites  of targeted  expression 
in transgenic  animals.  We have previously described mice 
transgenic for LT under the control of the rat insulin pro- 
moter  (RIP-LT  mice).  This  somewhat  leaky promoter  is 
expressed  in  the  pancreatic  islets  of Langerhans,  proximal 
convoluted tubules  in  the  kidney  (16,  17),  and skin.  The 
expression  of LT in these circumstances results in an infil- 
trate  consisting of T  cells,  B  cells,  and macrophages at the 
sites of cytokine expression and results in a ruffled hair phe- 
notype (18). A  similar inflammatory process is seen in islets 
of RIP-TNF-et mice (18,  19). Tissue damage does not oc- 
cur spontaneously in either RIP-LT or 1LIP-TNF-et mice, 
but can be induced by coexpression in the islets of the B7-1 
costimulatory molecule which activates  infiltrating  T  cells 
resulting  in beta  cell  destruction  and  diabetes  (5,  7).  The 
mechanism  of the  LT-induced  inflammatory  process  has 
not been elucidated,  nor have the relative contributions of 
the LT transgene and products of the cells in the infiltrates. 
LT, in addition to its role in inflammation, plays a crucial 
and unique role in lymphoid development and tissue orga- 
nization.  This is apparent from our analysis of mice made 
selectively deficient in LT expression  through the  process 
of homologous recombination (20).  Such LT knockout mice 
are  devoid  of all  peripheral  and  mesenteric  lymph  nodes 
and Peyer's patches.  Splenic organization is disrupted with 
the loss of usual compartmentalization into T  and B cell ar- 
eas.  Since  LT-deficient  mice  produce  normal  levels  of 
TNF-cx,  it  is  apparent  that  this  function  in lymphoid  or- 
ganogenesisis is peculiar to LT. The mechanism of LT's ef- 
fect in lymphoid organogenesis has not been investigated. 
Here we report the results of studies in which we evalu- 
ated RIP-LT mice to test the  hypothesis  that  chronic in- 
flammation represents lymphoid neo-organogenesis and that 
LT plays a crucial and identical role in both. We found that 
the  mononuclear accumulations  in pancreata  and  kidneys 
are  similar  if not  identical  to  organized  lymphoid  tissue 
with regard to cellular composition, compartmentahzation, 
a  specialized  vascular  system  with  expression  of markers 
characteristic  of vessels in lymph nodes and ultrastructural 
appearance of high endothelial venules, and reactivity to an 
exogenous antigen. We show that even RIP-LT mice that 
lack the recombination activating gene 2 protein  (RIP-LT 
RAG-2  -/-  mice)  and  thus  any  additional  cytokines  de- 
rived from mature T  or B cells express endothelial adhesion 
markers,  VCAM-1,  ICAM-1,  and  MAdCAM-1,  that  are 
likely to initiate mononuclear accumulation. Therefore, we 
propose  that LT-induced chronic inflammation  is actually 
lymphoid neogenesis and that the cytokine recapitulates in 
the adult its  activities in embryogenesis, in part through its 
ability to induce changes in the vasculature. This provides a 
unifying model for lymphoid development and inflamma- 
tion  and  has  implications  for  determinant  spreading  and 
clinical exacerbation in autoimmune disease. 
Materials and Methods 
Mice.  The generation of RIP-LT transgenic  mice has been 
described  (17). Animals were backcrossed to C57BL/6 (The Jack- 
son Laboratory, Bar Harbor, ME) or to mice lacking the RAG-2 
gene (21). A breeding nucleus of the latter  was kindly provided 
by Dr. Frederick Alt and maintained under specific pathogen-free 
conditions. These mice fail to produce mature B or T  lympho- 
cytes. The presence of the RIP-LT transgene  and of the RAG-2 
deletion was  determined by Southern blot hybridization as de- 
scribed  (17, 21). FACS analysis for the presence of CD3 + cells in 
peripheral  blood was performed to ascertain  the absence  of ma- 
ture lymphocytes in the R_AG-2 -/- animals. To achieve maximal 
transcription  from the insulin  promoter, some animals were kept 
on a high-fat diet and given 10% sucrose in drinking water. 
Primary Antibodies  for FACS and Immunohistochemistry.  The fol- 
lowing primary antibodies  were used  for immunohistochemistry 
or for flow  cytometry: YN  1/1.7  (specific  for ICAM-1  [22]), 
MK/2 (specific for VCAM-1 [23]), RA3-6B2 (specific  for the B-cell 
restricted  determinant  of B220;  Ca/tag Laboratories,  South San 
Francisco,  CA);  F4/80  (specific for  macrophages);  anti-CD8a- 
Phycoerythrin  (PE; GIBCO  BRL,  Gaithersburg,  MD);  anti- 
CD4-PE  (GIBCO  BRL);  FITC-labeled  anti-mouse  imnmno- 
globulin (Sigma); N418 (specific for the p150/90 132 integrin ex- 
pressed on dendritic cells (24); a kind gift of  Dr. Ralph Steinman); 
FDC-M1 (specific for mouse follicular dendritic cells (25); a kind 
gift  of Dr.  M.H.  Kosco-Vilbois);  PE-anti-mouse  CD3-epsilon 
(Pharmingen,  San  Diego,  CA).  MECA-367  (specific for MAd- 
CAM-1 [26]), MECA-79 (specific for PNAd [27]), and MJ 7/18 
(specific for endoglin [28]) were generously provided by Dr. Eu- 
gene Butcher. 
Flow Cytometry.  Cells  were isolated from lymph nodes and kid- 
neys by gentle pressure  with microscope slides and washed three 
times in Hanks' medium. Lymphocytes were purified from the kid- 
ney preparations  by centrifugation over Histopaque-1090 (Ficoll/ 
Hypaque; Sigma).  Cells  were washed once with  staining  buffer 
(5% fetal calf serum,  10 mM sodium azide in PBS), and incubated 
with the appropriate biotinylated primary antibodies  in 3% mouse 
serum (Sigma) in staining buffer for one hour. For B cell staining, 
fetal bovine serum was used instead  of mouse serum. After three 
washes  in  staining  buffer,  incubation  with  streptavidin-labeled 
FITC was performed.  For double staining,  cells were incubated 
with a second primary antibody and a PE-labeled secondary anti- 
body specific for immunoglobulin of the  species  of the second 
primary antibody, washed three times and fixed in 2% paraform- 
aldehyde (Sigma). Samples were analyzed with a FACScan  |  flow 
cytometer (Becton Dickinson,  Mountain View,  CA) for single 
stained  cells and with  a  FACStarplus |  flow cytometer (Becton 
Dickinson)  for  double  stained  cells using  LYSYS  software. 
25,000-50,000 cells were analyzed per sample. For FITC-stained 
cells, a 530/30 filter was used; for PE-labeled  cells, a 575/26 filter 
was used. 
Immunohistochemistry.  Tissues were fixed in periodate/lysine/ 
paraformaldehyde  (PLP) (29) fixative overnight, processed through 
three consecutive sucrose  solutions  (10, 20, and 30%), and snap 
frozen in Tissue Tek compound (Miles, Elkhart,  IN). Tissue sec- 
tions were cut with a Cryocut 1800  cryostat (Reichert Young, 
Deerfield, IL) at 7 p~m and stored at -20~  Sections were air dried 
and  rehydrated  for  10  Inin  in  wash  buffer  (0.1 M  phosphate 
buffer,  pH 7.3,  with 0.01%  Triton X).  To prevent background 
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antibodies,  sections  were  treated with  0.3%  I-I202 in methanol 
and with 10% normal goat serum (Pierce  Chem. Co., Rockford, 
IL). Incubation with the primary antibody was performed for 1-3 h. 
After three  rinses  with  wash buffer,  an appropriate  biotinylated 
species-specific secondary  antibody (GIBCO BRL,  Gaithersburg, 
MD) was applied. Then, after incubation with horseradishperoxi- 
dase-streptavidin  (Vector Laboratories,  Burlingame,  CA),  DAB 
(Sigma) was used for the color reaction.  Slides were counterstained 
with  methyl  green  (Sigma) and  coverslipped  with  Permount 
(Fisher Scientific, Pittsburgh,  PA). 
Fluorescence Microscopy.  Tissues were fixed in 2% paraformal- 
dehyde/5% sucrose for 30 min, infused with 20% sucrose for 1.5 
h,  and  snap  frozen  in  Tissue-Tek  compound.  Tissue  sections 
were  cut with  a Cryocut 1800  cryostat at  5  I.LM and stored at 
-20~  Sections were air dried,  fixed in acetone for 10 s, and re- 
hydrated in wash buffer (PBS, pH 7.4) for 10 rain.  For identifica- 
tion ofT and B lymphocytes sections were incubated for 1 h with 
directly conjugated monoclonal antibodies  145-2C11-FITC (anti- 
CD3)  and RA3-6B2-PE (anti-B220)  (PharMingen,  San  Diego, 
CA) in staining buffer (PBS, 2.5% Blotto (Pierce),  10% rabbit se- 
rum (Sigma). Plasma  cells were stained  as above with FITC-la- 
beled anti-mouse immunoglobulin. Stained  sections  were rinsed 
three times  in wash buffer,  coverslipped with Gel/Mount  (Bio- 
meda Corp., Foster City, CA) and observed by UV-light micros- 
copy using a Zeiss Axioskop microscope (Carl Zeiss, Inc., Thorn- 
wood, NY). Kodak Ektachrome P1600 film was used. 
Hematoxylin-eosin Stains.  Tissues were fixed in neutral buffered 
zinc-formalin,  embedded in para~in, sectioned at 5 Ixm, and stained 
with hematoxylin and eosin following standard techniques. 
Electron Microscopy.  Animals were euthanized by inhalation of 
Metofane (Methoxyflurane; Pitman-Moore, Inc., Mundelein, IL) 
and perfused with 0.1 M phosphate buffer and PLP. Tissues were 
removed and held in PLP for 1 h. After three changes  of phos- 
phate buffer,  tissues were washed in phosphate buffer overnight. 
Tissues were postfzxed with 1% glutaraldehyde  in 0.1 M  sodium 
cacodylate for an additional  one hour,  and washed three  times 
with 0.1 M sodium cacodylate. After postfixation in 1.33% osmium 
tetroxide  for 1 h,  tissues were washed three  times  with  0.1  M 
s-collidine,  dehydrated in a graded alcohol chain, and embedded in 
Epon. After sectioning at 60 nm, the tissue sections were stained 
with uranyl acetate and lead citrate. Sections were viewed on a Zeiss 
(Oberkochen, Germany) EM10B electron microscope at 80KV. 
Plaque Forming Ceil Assay.  Mice were immunized with  2  ￿ 
108 sheep red blood cells (SR_BC) i.v. and boosted 10 d later with 
the same number of i.p.  SRBC. 6 d after the second immuniza- 
tion,  the animals  were killed  by cervical  dislocation  and lymph 
nodes,  spleens,  and  kidneys  were  removed.  The  organs  were 
teased and ceils were washed three times  in Hanks' balanced salt 
solution.  Lymphocytes were purified from the  kidney prepara- 
tions by centrifugation over Histopaque-1090  (Ficoll/Hypaque; 
Sigma). SRBC were washed three times, mixed with agarose and 
lymphocytes, and spread  onto microscope slides precoated with 
agarose. After incubation in Hanks' balanced salt solution for 90 
rain at 37~  complement (Rockland, Gilbertsville, PA) was added 
to the medium and plaques  (IgM) were counted 1 h later. For in- 
direct plaques  (IgG), an anti-mouse IgG antibody was added be- 
fore incubation with complement (30). 
Results 
L T  Expressing  Tissues Have the Morphologic Appearance of 
Lymphoid Organs.  We  previously  reported  that  RIP-LT 
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mice express the transgene in the pancreatic beta cells and 
the proximal tubuli of the kidney (17,  18), as had been re- 
ported for other RIP-transgenic  mice (16).  The transgene 
is also expressed in the skin. We also reported that the ex- 
pression of the RIP-LT transgene leads to a remarkable in- 
flammation only at those local sites.  Here we provide an in 
depth analysis of the infiltrates induced by the local expres- 
sion in kidney and pancreas. Skin has not been further ana- 
lyzed. We found that the infiltrates are similar to each other 
and to lymphoid organs. 
There were obvious gross changes in the  appearance  of 
the RIP-LT kidneys. Macroscopically they were pale with 
surface protrusions (Fig.  1 A). Kidney sections stained with 
hematoxylin and eosin showed that the protrusions on the 
kidney surface were due to massive accumulations ofmono- 
nuclear cells.  Though these  aggregates were most obvious 
immediately  under  the  kidney  capsule,  they  were  also 
present  deeper  in  the  organ  (Fig.  1,  B  and  C).  No  such 
mononuclear accumulation was present in kidneys oftrans- 
gene-negative  litter  mates  (Fig.  1  B).  There  was  no  evi- 
dence of tissue damage or cell death in pancreata or kidneys 
of RIP-LT  animals.  Aggregations  of cells  with  the  mor- 
phologic  appearance  of primary  and  secondary  follicles 
were apparent in kidneys of RIP-LT mice immunized with 
SRBC (Fig.  1 C). 
The  Cellular Composition  and  Organization  of the Infiltrate 
Caused by RIP-L T Is Similar to That of a Lymph Node.  Our 
previously  reported  immunohistochemical  analysis  of the 
pancreatic RIP-LT infiltrate revealed the presence ofCD4 § 
and CD8 + T  cells,  B220 +, IgM  + B  cells and F4/80 + mac- 
rophages  (17,  18).  Here  we  further  evaluate  the  cellular 
composition  and  organization  of both  the  pancreatic  and 
kidney infiltrates. We used primarily immunohistochemical 
techniques to analyze pancreatic infiltrates as this allowed us 
to  distinguish  between  the  islets  and peripancreatic  lymph 
nodes. FACS analysis was used primarily on kidney because 
of ease in obtaining larger numbers of lymphoid cells from 
that  organ  of RIP-LT mice and the  absence  of any lym- 
phocytes in and around kidneys of normal mice. 
A  central  characteristic  of lymphoid tissues  is the  com- 
partmentalization  of B  cells  and T  cells  and the  organiza- 
tion of B cells in primary follicles and germinal centers (sec- 
ondary follicles).  In our previous studies  of RIP-LT mice 
we reported the presence of CD4 + and CD8 + T  cells and 
B220 +  B  cells  in  infiltrates  in  the  pancreata  of RIP-LT 
mice (17). Though not specifically noted in that publication, 
compartmentalization was apparent in the  chronic inflam- 
mation caused by LT in that  T  cells  and B  cells  occupied 
different areas.  Here we show a similar compartmentaliza- 
tion of T  and B  cells in RIP-LT kidneys (Fig. 2 A). 
Antigen-presenting  cells  characteristic  of lymph  nodes 
were  detected  in  the  peri-insular  infiltrates  of RIP-LT 
mice. These included cells staining with N418, an antibody 
that stains the  p150/90  [~2 integrin  expressed  on dendritic 
cells.  Though this antigen is not unique  to dendritic  cells, 
its expression in RIP-LT islets  and its absence in normal is- 
lets is consistent with their presence (Fig. 2, B and C). Cells 
staining with  FDC-M1,  an antibody specific for follicular Figure  1.  1LIP-LT  transgenic kidneys resemble lymphoid organs. (,'t) 
Macroscopically, the kidney of the non-transgenic animal is pale, with 
many surface protrusions (left). The kidney of the non-transgenic mouse is 
red, with no protrusions (right). (B) H- and E-stained paraffin embedded 
tissue sections show that the protrusions on the surface of the P,  IP-LT 
transgenic kidney (left) are caused by massive cellular accumulations. No 
infiltrate is visible in  a non-transgenic kidney (right) (3￿  (C)  Higher 
magnification of a RIP-LT transgenic kidney (31 ￿  Mononuclear infil- 
trating cells are clearly discernible, with the appearance of  primary follicles 
and germinal centers. 
dendritic  cells, were also present in the infiltrate  (Fig.  2  D). 
As follicular dendritic cells are thought to play an important 
role in the maturation of B  cells in lymph nodes and spleen, 
and interdigitating  dendritic  cells present antigen to T  cells, 
the  presence  of these  two  cell  types  in  the  infiltrate  of 
I<IP-LT  animals  is  particularly  notable.  In  addition,  fully 
differentiated B  cells (plasma cells) were detected in the in- 
filtrates in kidney (Fig. 2 E) and in pancreas (not shown)  of 
SRBC-imrnunized  RIP-LT  mice.  This result is suggestive 
of in loco maturation of the B  cells. 
To determine whether the infiltrating cells were present 
in the same proportions  as in a conventional  lymphoid or- 
gan,  flow  cytometric  analysis  was performed  on  cells  iso- 
lated  from  R.IP-LT  infiltrates.  We  have  previously  com- 
pared pancreatic infiltrates of R.IP-TNF-e~ and NOD  mice 
by FACS  analysis (18).  Such studies  could be criticized for 
the possibility of contamination by cells from peripancreatic 
lymph nodes. Furthermore,  the number of cells obtained in 
this way, particularly from P,1P-LT pancreata is quite small. 
Therefore, as we extended  our study here we concentrated 
our analysis on lymphoid cells obtained from R.IP-LT kid- 
neys and compared them with the composition of a pool of 
mesenteric and peripheral lymph nodes.  Mononuclear  cells 
were  stained  with  antibodies  specific  for  T  cells,  B  cells, 
and  macrophages.  The  cellular  composition  of the  kidney 
infiltrate  was  very  similar  to  that  of lymph  nodes  of the 
same  animal  (Fig.  3).  The  percentage  of B  cells  in lymph 
nodes and kidneys was virtually identical.  There was a some- 
what  lower  proportion  of T  cells  present  in  kidney  infil- 
trates, while  there were slightly more F4/80-positive  mac- 
rophages in 1LIP-LT kidneys than in lymph nodes,  though 
they were  still a small percentage  of the  total.  As expected 
from the higher number ofCD3 + cells in lymph nodes, the 
absolute  numbers  of CD4 +  and  CD8 §  cells was higher  in 
lymph nodes than in kidneys.  However, the ratio ofCD4 + 
to  CD8 +  cells  in  the  two  organs  was  virtually  identical. 
These data show that all cell types characteristic  of a lymph 
node can be found in a chronic infiltrate caused by LT, and 
that the proportion of the cells in the infiltrate is very simi- 
lar to that in lymph nodes. 
RIP-LT Induced  Inflammation  Indudes  Vessels With  Mor- 
phologic and Antigenic  Characteristics of Those in Lymph Nodes. 
To determine  whether the presence of LT leads to the de- 
velopment of vessels characteristic  of lymph nodes, we eval- 
uated  tissues  from  P,  IP-LT  mice  and  transgene-negative 
littermates morphologically in the electron microscope and 
histochemically for the expression  of markers characteristic 
of lymph node vessels. In these studies we concentrated  on 
the  pancreas  as  this  allowed  a  comparison  with  previous 
studies  of vessels in the pancreatic infiltrates in NOD  mice 
(18, 31,  32).  Furthermore,  the location  of LT-expressing 13 
cells and the infiltrates  are more easily defined in the pan- 
creas than  in  the  kidney.  High  endothefial  venules  (HEV) 
are  specialized  vessels,  usually  present  in  lymph  nodes, 
which  are  the  sites  of migration  of lymphocytes from  the 
bloodstream  into  the  lymphoid  organ.  Lymph node  HEV 
have  a  characteristic  ultrastructural  morphology,  with  an 
increase in vessel wall thickness,  protrusions into the lumen 
of the vessels, and enlarged, plump nuclei,  and they express 
peculiar adhesion molecules called addressins. 
Endothelial  cells  in  vessels  in  the  vicinity  of endocrine 
cells in the pancreas of transgene-negative  controls had the 
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dendritic cells, and plasma cells in the inflammatory  lesions of  RIP-LT mice. (A) Organization  into B and T cell areas as revealed by immunofluorescence 
staining with anti-CD3-FITC  (green;  left)  and anti-B220-PE (orange;  right)  (magnification  62￿  (B) Absence of  staining with N418, an antibody specific 
for the p150/90 [32 integrin expressed on dendritic cells, in non-transgenic control tissue. (C) N 418 staining cells are present among the cells of the 
mononuclear infiltrate of  RIP-LT mice. (D) Cells staining with FDC-M1, an antibody specific for follicular dendritic cells in the peri-insular infiltrate of 
a RIP-LT mouse. (E) Cells exhibiting cytoplasmic  staining with anti-mouse immunoglobulin-FITC indicates the presence of  plasma cells in the kidney 
of  an immunized RIP-LT mouse. (125  ￿  ). 
morphology typical of a non-inflamed pancreas. The vessel 
wall  was  smooth  and  lacked  protrusions  and  exhibited 
elongated nuclei  (Fig. 4 A). Blood cells  are not obvious in 
the  vessels  of these  extensively  perfused  mice.  Vessels  in 
pancreata of R.IP-LT mice showed the typical morphology 
of HEV  (12,  33)  with an irregular  and increased thickness 
of the  vessel  wall,  protrusions  into  the  vessel  lumen,  and 
enlarged and plump nuclei (Fig. 4  B). These findings dem- 
onstrate  that  LT  expression  leads  to  the  development  of 
high  endothehal  venules.  These  results  therefore  indicate 
that the expression of LT at a local site results in the differ- 
entiation of vessels into HEV. As HEV are the sites  of mi- 
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gration  of lymphocytes  from  the  bloodstream  into  lym- 
phoid organs, this suggests that changes in endothehal cells 
could  contribute  to  the  development  of the  infiltrates  in 
RIP-LT mice. 
A complex system of  vascular addressins is responsible for 
lymphocyte extravasation into lymphoid organs. We inves- 
tigated whether  the  adhesion molecules that are  expressed 
on vessels in lymphoid tissues are also expressed in the re- 
gions of LT-induced  chronic inflammation.  The  adhesion 
molecules  PNAd  (peripheral  node  addressin)  and  MAd- 
CAM-1  (mucosal  addressin-ceU  adhesion  molecule  1)  are 
involved in the recirculation oflymphocytes into lymphoid Lymph  Node 
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Figure  3.  Flow cytometric analysis for Ig, CD3,  F4/80, CD4, and 
CD8+ Cells were obtained from a pool  of mesenteric and peripheral 
lymph nodes and from the kidney of a RIP-LT transgenic animal and 
stained with the indicated antibodies as described in Experimental Pro- 
cedures. The intensity of staining and relative percentages of B cells, T 
cells, and macrophages were very similar in lymph node and transgenic 
kidney. The ratio ofCD4  + cells to CD8 + cells in the kidney is the same 
as in a lymph node. The somewhat higher percentage of F4/80 + cells in 
the kidney infiltrates could be due to staining ofrnesangial cells. Solid line 
indicates staining with an irrelevant control antibody; dotted hne indicates 
staining with anti-Ig, anti-CD3, anti-F4/80, anti-CD4, or anti-CD8. 
regions and mucosal tissues  (26-28).  In the adult, PNAd is 
expressed predominantly on endothelial  cells  in peripheral 
lymph nodes;  MAdCAM-1  is found mainly in mesenteric 
lymph  nodes  and  Peyer's patches.  To  determine  if these 
adhesion  molecules  were  expressed  in  the  pancreata  of 
RIP-LT  mice,  immunohistochemical  studies  were  per- 
formed. Though MAdCAM-1 was expressed constitutively 
at low levels in the exocrine pancreas of RIP-LT-negative 
mice, it was clearly upregulated on endothelial cells of ves- 
sels  within  the  infiltrate  in RIP-LT mice.  This  upregula- 
tion was  restricted  to vessels  within  the  peri-insular  infil- 
trate, and was not seen on vessels within the RIP-LT islets 
(Fig. 5, A  and B). PNAd was not detected on any vessels  in 
the  pancreata  of non-transgenic  mice  (Fig.  5  C),  but  was 
present  on vessels  located  within  the  chronic  infiltrate  of 
the  peri-insular  lesions  of RIP-LT  animals.  As  was  true 
with MAdCAM-1, PNAd expression was restricted to ves- 
sels  within  the  infiltrate.  Endothelial  cells  located  within 
the islets  of klP-LT  animals did not express PNAd (Fig. 5 
D).  These studies  also suggest that LT expression  resulted 
in  angiogenesis.  For example,  in Fig.  5  B,  a  larger vessel, 
that  does  not  express  MAdCAM-1,  is  present  in  close 
proximity to an islet.  A  smaller  vessel,  highly positive  for 
MAdCAM-1,  is  growing  out  of  this  larger  vessel  and 
branching out into  the location of the infiltrate.  Immuno- 
histochemical analysis  with an antibody specific for endog- 
lin,  a marker expressed by most endothelial  cells  (28),  also 
indicated angiogenesis in a peri-insular and intra-insular lo- 
cation in RIP-LT mice (data not shown). 
The Cells of the Infiltrate Can Respond to an Exogenous An- 
tigen.  While  the  presence  of LT  was  sufficient  for  the 
development  of the  morphologic  appearance  and  cellular 
composition of a lymphoid organ,  the  central property of 
organized lymphoid tissue  is its  ability  to generate  an im- 
mune response. We first studied whether cells isolated from 
R.IP-LT kidneys and pancreata could respond to T  and B 
cell mitogens.  A  significant proliferative  response  was  in- 
duced by the T  cell mitogen Con A  and the B cell mitogen 
LPS (data not shown).  In order to investigate the ability of 
the LT-induced infiltrate  to generate an immune response 
to an  exogenous antigen,  RIP-LT mice were immunized 
with  SRBC  and lymphocytes were  obtained  from lymph 
nodes,  spleens,  and kidneys.  (It was not possible to obtain 
sufficient cells from pancreata for these studies.)  Direct plaque- 
forming cell  (PFC)  assays  performed to  evaluate  the pres- 
ence of cells producing IgM to SRJ3C revealed that in lym- 
phocytes  obtained  from kidneys  from SRBC  immunized 
R.IP-LT mice, the number of PFC was comparable to that 
in lymph nodes (Table I). To determine whether IgG pro- 
duction and isotype class switching occurred in the lymphoid 
accumulations in R.IP-LT kidneys, indirect PFC assays were 
performed  with  cells  from SRBC  boosted RIP-LT mice. 
IgG-SRBC PFC were  present  in  the  kidneys of R.IP-LT 
mice  (Table  I).  These  experiments  show  that  the  newly 
formed "lymphoid organs" in the kidneys of RIP-LT ani- 
mals are able to generate an immune response, as shown by 
their  ability  to  produce  SR_BC-specific  IgM-producing 
cells  and to provide T  cell help to perform immunoglobu- 
lin class switching. 
L T, Even in the Absence of  Mature Lymphocytes, Induces Several 
Characteristics of a Lymphoid Organ.  As indicated  above,  the 
expression  of LT in  tissues  of immunocompetent  animals 
1466  Lymphotoxin Causes Lymphoid Neogenesis Figure 4.  IMP-LT induced inflammation includes vessels with the morphologic characteristics of HEV. (A) In the electron microscope, vessels from a 
non-transgenic animals show even, thin vessel walls. No protrusions are seen. (B) Vessels from a KIP-LT transgenic animal show protrusions into the lu- 
men and thickening of the endothehal cell body. (t?, endocrine cells; *, pancreatic duct; arrows indicate endothehal cells.) (6,000  ￿ 
resulted  in  infiltrates  consisting  of all  cell  types  normally 
seen  in  a  lymphoid organ.  The  development  of these  in- 
flammatory  lesions  could  be  the  direct  effect  of LT,  or 
could be partly mediated by factors derived from the infil- 
trating  cells.  To  gain  insight  into  the  mechanism  of LT's 
induction of lymphoid cell accumulation in the absence of 
lymphocytes,  and  to  determine  whether  factors  derived 
from mature lymphocytes were necessary for the induction 
of adhesion  molecules  to  occur,  we  evaluated  RIP-LT 
RAG-2  -/-  mice.  These  mice,  shown to be homozygous 
for the RAG-2 knockout mutation by Southern blot anal- 
ysis, showed a complete absence ofCD3 + T  cells  in FACS 
analysis of peripheral blood, Immunohistochemical analyses 
of markers expressed  on CD4 + and CD8 + T  cells,  B  cells, 
macrophages,  dendritic  ceils  and  follicular  dendritic  cells 
were  carried  out  on pancreatic  tissue  sections  of KIP-LT 
RAG-2  -/-  mice.  Only  a  few  inflammatory  cells  were 
present in the kidneys and pancreata of  RIP-LT RAG-2 -/- 
mice. These were mainly dendritic cells,  follicular dendritic 
cells, macrophages,  and a few immature lymphocytes (data 
not shown).  Therefore,  the  elicitation  of even  a  minimal 
infiltrate was not dependent on factors derived from mature 
lymphocytes. Because these studies establish that hardly any 
inflammatory cells  are present  at the sites  of LT expression 
in IMP-LT RAG-2 -/- mice, these animals are appropriate 
to analyze the  effects of LT in  the  absence  of a major in- 
flammatory lesion. 
R.IP-LT  RAG-2  -/-  mice  were  investigated  to  deter- 
mine  whether  LT directly induces  expression  of adhesion 
molecules  in vivo.  Previous  studies  have  demonstrated  its 
abihty to induce VCAM- and ICAM-1 on endothehal cells 
in  vitro  (11,  12),  and  its  close  relative,  TNF-o~  has  been 
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shown to also induce MAdCAM-1  in vitro  (34). We have 
previously reported that the adhesion molecules ICAM-1 and 
VCAM-1 are upregulated in RIP-LT mice on vessels within 
islets  and  in  the  peri-insular  space.  However,  ICAM-1  is 
also  expressed  on  some  of the  infiltrating  cells  (18).  The 
high levels oflCAM-1  and VCAM-1 on vessels in the islets 
even in areas lacking infiltrates  suggests that the transgene- 
derived LT, rather than factors derived solely from infiltrat- 
ing cells,  induces these molecules.  To critically address the 
role of  LT in ICAM-1 and VCAM-1 upregulation, adhesion 
molecules were evaluated in pancreata of PdP-LT RAG-2 
-/- mice and their non-transgenic httermates.  The low con- 
stitutive  expression  of ICAM-1  in non-transgenic RAG-2 
-/-  mice  was  comparable  to  that  observed  in  non-trans- 
genic immunocompetent animals.  In RIP-LT RAG-2 -/- 
animals, there was clear upregulation of the adhesion mole- 
cule on the endothehal cells of  vessels throughout the islets, 
in the peri-insular space, and in the exocrine tissue in close 
vicinity to the islets  (Fig. 6 A). The increased ICAM-1 ex- 
pression  was  comparable  to  that  in  immunocompetent 
PdP-LT mice. Almost no expression of VCAM-1 was ob- 
served  in  RAG-2  -/-  non-transgenic  pancreatic  tissues. 
This confirmed our previous report in non-transgenic im- 
munocompetent mice (18). Upregulation of VCAM-1 was 
observed in RIP-LT-positive RAG-2 -/- pancreata (Fig. 6 
/3).  The  distribution  of VCAM-1  was the  same  as that  of 
ICAM-1. In order to quantify the upregulation oflCAM-1 
and  VCAM-1,  coded  tissue  sections  stained  for  ICAM-1 
and VCAM-1 were scored as showing normal or increased 
expression of the adhesion molecules.  Increased expression 
of ICAM-1 was seen in 100% of the islets  and VCAM-1 in 
98% of the islets  in 1LIP-LT-positive mice.  The difference Figure 5.  RIP-LT induced inflammation includes vessels  with biochemical characteristics  of  lymphoid tissues, (A) Very low constitutive expression of 
MAdCAM-1 on vessels  in the exocrine pancreas ofa transgene negative animal. (B) Increased expression of MAdCAM-1 on vessels  in the infiltrate of a 
RIP-LT transgenic animal. Note that the vessel expressing  MAdCAM-1 appears to be growing out of a larger vessel, suggesting  the possibility  of anglo- 
genesis. (C) No PNAd expression on vessels  in the pancreas of a non-transgenic littermate control. (D) PNAd expression in vessels  in the chronic infil- 
trate ofa RIP-LT animal. (125X). 
between  adhesion  molecule  expression  in  islets  of RIP- 
LT-negative  and  -positive  mice  is  statistically significant 
(P <0.005  by ANOVA).  These  findings demonstrate  that 
additional factors derived from mature lymphocytes are not 
necessary for  the  upregulation  of ICAM-1  and  VCAM-1 
by LT and suggest that LT can induce their expression. 
Vessels in  RIP-LT  RAG-1  -/-  pancreata were  studied 
for  markers  more  typical of lymph  nodes.  They  had  the 
typical morphology  of HEV  (not  shown)  indicating that 
the  presence  of LT  is suflficient to  cause  the  morphologic 
differentiation  of normal  vessels  into  HEV.  As  we  have 
shown previously that all [3 cells in RIP-LT animals express 
the  transgene  (17),  the  expression  of MAdCAM-1  and 
PNAd,  which  was  restricted to  the  sites of inflammation, 
rather than throughout the islets (Fig. 5), suggested either a 
role for the infiltrating mononuclear cells in the upregula- 
tion of these molecules, or a difference in the susceptibility 
of vessels in different anatomical locations to the effects of 
LT. In RIP-LT RAG-1  -/- mice, there was additional ex- 
pression of MAdCAM-1  on the vessels in the peri-vascular 
space  (Fig. 6  C).  Therefore,  LT in  the  absence  of mature 
lymphocytes  also  induced  increased  expression  of MAd- 
CAM-1.  The highly restricted expression of PNAd in the 
location of the infiltrate in immunocompetent RIP-LT an- 
imals  (Fig.  5)  suggests  the  possibility that  the  infiltrating 
cells had a  causative role in the  upregulation of this adhe- 
sion  molecule.  The  fact  that  PNAd  was  not  detected  in 
RIP-LT  pancreata  from  animals  that  lacked mature  lym- 
phocytes (Fig. 6  D) indicates that, in contrast to the obser- 
vations with VCAM-1, ICAM-1, and MAdCAM-1, addi- 
Table 1.  Plaque  Forming Cells in Kidneys of RIP-LT Mice 
Immunized with SRBC 
PFC/107 lymphoid cells 
Organ  Direct (IgM)  Indirect (IgG) 
Kidney  421  2,357 
LN (cervical)  470  5,370 
LN (mesenteric)  2,210  6,109 
Spleen  1,540  15,160 
Mice were immunized as indicated in Materials and Methods with 2 ￿ 
10  s SRBC i.v., boosted  10 d later with the same dose i.p., and killed 
6 d later. Data shown are representative of four experiments with simi- 
lar results. No lymphocytes were present in kidneys of RIP-LT nega- 
tive animals, and no PFC were obtained from kidneys of non-immu- 
nized RIP-LT mice. 
1468  Lymphotoxin Causes Lymphoid Neogenesis Figure 6.  Upregulation oflCAM-1, VCAM-1, and MAdCAM-1, but not PNAd on vessels in and around islets of  animals transgenic for R.IP-LT, but 
lacking mature lymphocytes. (A) ICAM-1 is upregulated in R.IP-LT RAG-2 -/- mouse on vessels throughout the islets, in the infiltrate, and even on 
some vessels in the exocrine pancreas in close proximity to the islets. (B) VCAM-1 is upregulated in the pancreas of R.IP-LT R.AG-2 -/- animal. Note 
that hke ICAM-1, VCAM-1 is upregulated on vessels throughout the islets, in the infiltrate, and even on some vessels in the exocrine pancreas in close 
proximity to the islets. (C) Expression of  MAdCAM-1 on vessels in the peri-imular space ofa B.IP-LT RAG-2 -/- mouse. (D) No e~pression of PNAd 
on vessels ofa RIP-LT RAG-2 -/- animal. (125￿ 
tional  factors  derived  from  mature  lymphocytes  are 
necessary for the upregulation of this adhesion molecule. 
Discussion 
Our data support  a  unifying model for lymphoid organ 
development and chronic inflammation.  We show that the 
chronic inflammation caused by local expression of LT has 
all the characteristics of functional lymphoid tissue.  All cell 
types normally found in lymphoid organs, including T  cells, 
B  cells,  plasma cells,  follicular dendritic cells, and other an- 
tigen-presenting  cells,  were  present  in  the  R.IP-LT- 
induced infiltrates.  The proportions of these cells were very 
similar to those observed in a lymph node. In addition to T 
and B  cell compartments, areas with the morphological ap- 
pearance  of primary  and  secondary follicles  were  present. 
The endothelial  cells  of the vessels in the infiltrates had the 
typical  morphology  of high  endothelial  venules  and  ex- 
pressed  ICAM-1  and VCAM-1,  molecules  usually associ- 
ated  with  chronic  inflammation,  and  PNAd  and  MAd- 
CAM-l,  molecules  normally  associated  with  vessels  in 
peripheral  or mesenteric  lymph  nodes.  In addition  to  the 
morphologic  characteristics  of organized  lymphoid tissue, 
the cells of the chronic infiltrate showed the functional at- 
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tributes of a lymphoid organ in their ability to generate a T 
cell--dependent  antibody  response  and  to  induce  class 
switching.  Lymphocytes in the newly organized lymphoid 
accumulations  in  the  pancreata  and  kidneys  of R.IP-LT 
mice are most likely derived from the recirculating pool of 
mononuclear cells, just as they are in normal lymph nodes. 
The organization into germinal centers and the presence of 
plasma cells  points to a local activation of these cells.  Stud- 
ies with R.IP-LT transgenic mice that lack secondary lym- 
phoid organs are under way to further investigate this ques- 
tion. 
The LT-induced upregulation of the adhesion molecules 
ICAM-1,  VCAM-1,  and  MAdCAM-I  and  the  morpho- 
logic appearance of HEV did not depend upon factors de- 
rived from mature  lymphocytes.  On  the  other hand,  ma- 
ture  lymphocytes,  in  addition  to  the  transgene  product, 
were necessary for the expression of PNAd. These findings 
suggest that many of the effects of  LT in lymphoid neogen- 
esis  are  direct  effects  of the  cytokine,  as  suggested  by in 
vitro studies (11, 34) or secondary to its expression, and not 
caused by factors derived  from infiltrating lymphoid cells. 
Other effects most likely require chemokines and other cy- 
tokines derived from local and infiltrating cells  and are sec- 
ondary or even independent of LT. Further studies are needed to explore the interactions of 
other  cytokines  and  chemokines  with  LT  in  lymphoid 
neo-organogenesis. There are several transgenic models in 
which local expression of cytokines leads  to the develop- 
ment of inflammatory lesions that in many respects are sim- 
ilar to those  described here.  Mice transgenic for TNF-Ix, 
IL-2, or IL-10 under the control of the insulin promoter 
show pancreatic inflammation, but do not develop sponta- 
neous diabetes (18,  19, 35, 36) and mice expressing IFN-o~ 
or IFN-',/under the same promoter develop both inflam- 
mation and diabetes (37-39). Mice transgenic for a modi- 
fied TNF-cl gene  develop arthritis  (40).  It is  not known 
whether the infiltrates in these systems also exhibit all the 
lymphoid organ characteristics that R.IP-LT mice do and 
whether and how LT participates. It is possible that LT and 
other cytokines induce converging pathways that contrib- 
ute  to these inflammatory events. It is  quite possible that 
LT plays  a critical role in these systems,  because of all the 
cytokine or  cytokine receptor knockout  mice  (including 
those  lacking the  p55  and/or  p75  TNF  receptors),  only 
LT-deficient mice lack lymph nodes.  It is therefore very 
probable that LT's role in the induction of lymphoid or- 
gans is unique. Answers to these questions may be provided 
in the analysis of e.g., RIP-IL-2 LTo~-/- mice being gener- 
ated now in our laboratory. 
Our work provides a functional implication and mecha- 
nism for the phenomena that have given rise  to the term 
"tertiary lymphoid tissue." This designation has been sug- 
gested for all tissues because they can be induced to recruit 
unique subsets  of lymphocytes in the setting of inflamma- 
tion (9). Consistent with this designation have been several 
previous reports that chronic inflammatory lesions resemble 
lymphoid tissues.  Clearly delineated T  and B cell areas can 
be  seen  in  inflamed synovium of patients  suffering from 
rheumatoid arthritis (41) and this tissue produces the same 
immunoglobulin isotypes as  does  a lymphoid organ  (42). 
Vessels  with  the  characteristics  of HEV  have  been  de- 
scribed in the  lesions of experimental allergic encephalo- 
myelitis  (43-46).  Thyroiditis in BB rats  is so similar to a 
secondary lymphoid organ that it has  been suggested that 
this inflammation in which very little tissue destruction oc- 
curs should be called "thyroid associated lymphoid tissue" 
(4).  Vessels  in the  insulitis  of prediaberic NOD  mice ex- 
press MAdCAM-1  and PNAd (31,  32). The characteristics 
of lymphoid neogenesis  noted  above  in  several  different 
types of chronic inflammatory lesions indicate that this pro- 
cess occurs throughout life in adults  and is not an isolated 
phenomenon peculiar to  the  transgenic  system described 
here.  The functional implication  of the  designation  "ter- 
tiary lymphoid tissue," namely the possibility that antigen 
can be presented at a local inflammatory site and contribute 
to determinant spreading (47),  is apparent from our work 
and provides an appreciation that the mechanism of inflam- 
mation may be very similar to the process of fetal lymphoid 
organogenesis. 
Our work provides a framework to  consider common 
mechanisms for lymphoid organogenesis and inflammation. 
The first cells observed in lymphoid organ development are 
lymphocytes that migrate from veins to the sites of the fu- 
ture lymph nodes (48). Though most studies evaluating LT 
regulation  have  concentrated  on  CD4+Thl,  CD8 +,  or 
pre-B cells  (49,  50),  and virus infected cells  (51),  LT can 
also be made by a variety of other cell types, including NK 
cells and astrocytes (10). Therefore, there are several possi- 
ble sources of LT that could contribute to lymph node for- 
marion  in  embryonic  development.  LT  in  development 
(whatever its source) and inflammation (from T  cells) could 
cause the infiltration ofmononuclear cells via upregulation of 
adhesion molecules and other changes in endothelial cells. 
The data presented here clearly show that LT alone is suffi- 
cient for the expression of the adhesion molecules ICAM-1, 
VCAM-1, and MAdCAM-1  and the morphologic changes 
characteristic of the high endothelial venules found in lym- 
phoid organs, and eventually leads to cellular and functional 
attributes of a lymphoid organ. 
The findings reported here provide insight into mecha- 
nisms that lead to lymph node development and of those 
forms of chronic inflammation that lead to the formation of 
lymphoid  tissues  in  inappropriate  locations.  They  imply 
that one cytokine, LT, not only plays a crucial role in these 
processes, but that it is sufficient for many of their associ- 
ated characteristics. Our work revealing LT as an initiating 
factor in  chronic inflammation provides a  clearer under- 
standing of these events. An even better understanding will 
come from our ongoing studies of KIP-LT mice that lack 
any endogenous LT (LT-c~-/- mice) and from the elucida- 
tion of the role of receptors, signaling pathways, and other 
LT-induced  proteins.  Such  studies  could  lead  to  highly 
specific therapies for a variety of diseases. For example, spe- 
cific LT-antagonists could be useful for the prevention of 
determinant spreading in autoimmune diseases. Engineered 
release of LT at sites of malignant lesions could lead to in- 
flammation and  provide a  local milieu  to  induce  an  im- 
mune response against  a tumor. Elucidation of the mecha- 
nisms of lymphoid organogenesis could also be important 
for the therapy of other diseases as well. Patients who re- 
ceive whole-body irradiation often develop an atrophy of 
their lymphoid tissues;  presently, few therapeutic modali- 
ties exist to influence the regeneration of these organs. It is 
possible that LT could be useful here. The lesions of pul- 
monary lymphoid hyperplasia seen in pediatric AIDS  pa- 
tients  have  characteristics  of a  lymphoid  organs  (52,  53) 
hinting at a role of LT and therapeutic implications of the 
findings reported here for some infectious diseases. 
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